DAY ONE BIOPHARMACEUTICALS I's ticker is DAWN and the CUSIP is 23954D109. A total of 125 filers reported holding DAY ONE BIOPHARMACEUTICALS I in Q1 2023. The put-call ratio across all filers is 0.46 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $29 | -17.1% | 2,138 | 0.0% | 0.00% | – |
| Q1 2024 | $35 | -72.0% | 2,138 | -75.1% | 0.00% | -100.0% |
| Q4 2023 | $125 | +17.9% | 8,590 | -0.4% | 0.00% | 0.0% |
| Q3 2023 | $106 | +39.5% | 8,628 | +35.7% | 0.00% | 0.0% |
| Q2 2023 | $76 | +94.9% | 6,360 | +119.2% | 0.00% | – |
| Q1 2023 | $39 | -49.4% | 2,901 | -18.9% | 0.00% | -100.0% |
| Q4 2022 | $77 | -99.9% | 3,577 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $72,000 | +35.8% | 3,577 | +21.0% | 0.00% | – |
| Q2 2022 | $53,000 | +76.7% | 2,957 | -2.5% | 0.00% | – |
| Q1 2022 | $30,000 | – | 3,034 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 4,965,588 | $113,066,000 | 1.82% |
| Boxer Capital, LLC | 1,189,943 | $27,095,000 | 0.96% |
| BVF INC/IL | 918,975 | $20,925,000 | 0.78% |
| Samsara BioCapital, LLC | 202,500 | $4,611,000 | 0.57% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 818,980 | $18,648,000 | 0.33% |
| Perceptive Advisors | 1,512,094 | $34,430,000 | 0.22% |
| Rock Springs Capital Management LP | 373,739 | $8,510,000 | 0.17% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 434,423 | $9,892,000 | 0.13% |
| HealthCor Management, L.P. | 103,717 | $2,362,000 | 0.09% |
| VIKING GLOBAL INVESTORS LP | 1,341,396 | $30,544,000 | 0.09% |